Literature DB >> 30570304

Meta-analysis of the efficacy of psychological and medical treatments for binge-eating disorder.

Anja Hilbert1, David Petroff1, Stephan Herpertz2, Reinhard Pietrowsky3, Brunna Tuschen-Caffier1, Silja Vocks1, Ricarda Schmidt4.   

Abstract

OBJECTIVE: To provide a comprehensive meta-analysis on the efficacy of psychological and medical treatments for binge-eating disorder (BED), including those targeting weight loss.
METHOD: Through a systematic search before March 2018, 81 published and unpublished randomized-controlled trials (RCTs), totaling 7,515 individuals with BED (Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition [DSM-IV] and Fifth Edition [DSM-5]), were retrieved and analyzed using random-effect modeling.
RESULTS: In RCTs with inactive control groups, psychotherapy, mostly consisting of cognitive-behavioral therapy, showed large-size effects for the reduction of binge-eating episodes and abstinence from binge eating, followed by structured self-help treatment with medium-to-large effects when compared with wait-list. Pharmacotherapy and pharmacological weight loss treatment mostly outperformed pill placebo conditions with small effects on binge-eating outcome. These results were confirmed for the most common treatments of cognitive-behavioral therapy, self-help treatment based on cognitive-behavioral therapy, and lisdexamfetamine. In RCTs with active control groups, there was limited evidence for the superiority of one treatment category or treatment. In a few studies, psychotherapy outperformed behavioral weight loss treatment in short- and long-term binge-eating outcome and led to lower longer-term abstinence than self-help treatment, while combined treatment revealed no additive effect on binge-eating outcome over time. Overall study quality was heterogeneous and the quality of evidence for binge-eating outcome was generally very low.
CONCLUSIONS: This comprehensive meta-analysis demonstrated the efficacy of psychotherapy, structured self-help treatment, and pharmacotherapy for patients with BED. More high quality research on treatments for BED is warranted, with a focus on long-term maintenance of therapeutic gains, comparative efficacy, mechanisms through which treatments work, and complex models of care. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30570304     DOI: 10.1037/ccp0000358

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  50 in total

1.  A double-blind, placebo-controlled study of vortioxetine in the treatment of binge-eating disorder.

Authors:  Jon E Grant; Stephanie Valle; Elizabeth Cavic; Sarah A Redden; Samuel R Chamberlain
Journal:  Int J Eat Disord       Date:  2019-04-02       Impact factor: 4.861

2.  Predictors of treatment response durability in psychotherapy for binge-eating disorder: Examining the roles of self-discrepancy, self-directed style, and emotion dysregulation.

Authors:  Vivienne M Hazzard; Carol B Peterson; Ross D Crosby; Lauren M Schaefer; Kathryn E Smith; Scott G Engel; Scott J Crow; Stephen A Wonderlich
Journal:  Int J Eat Disord       Date:  2020-10-29       Impact factor: 4.861

3.  A developmental framework of binge-eating disorder based on pediatric loss of control eating.

Authors:  Marian Tanofsky-Kraff; Natasha A Schvey; Carlos M Grilo
Journal:  Am Psychol       Date:  2020 Feb-Mar

4.  Randomized controlled trial testing the effectiveness of adaptive "SMART" stepped-care treatment for adults with binge-eating disorder comorbid with obesity.

Authors:  Carlos M Grilo; Marney A White; Robin M Masheb; Valentina Ivezaj; Peter T Morgan; Ralitza Gueorguieva
Journal:  Am Psychol       Date:  2020 Feb-Mar

5.  Associations between physical activity and eating-disorder psychopathology among individuals categorised with binge-eating disorder and bulimia nervosa.

Authors:  Stephanie G Kerrigan; Janet A Lydecker; Carlos M Grilo
Journal:  Int J Clin Pract       Date:  2019-09-11       Impact factor: 2.503

6.  Randomized Controlled Trial of Behavioral Weight Loss and Stepped Care for Binge-Eating Disorder: 12-Month Follow-up.

Authors:  Carlos M Grilo; Marney A White; Valentina Ivezaj; Ralitza Gueorguieva
Journal:  Obesity (Silver Spring)       Date:  2020-09-27       Impact factor: 5.002

7.  Examining sex as a predictor and moderator of treatment outcomes for binge-eating disorder: Analysis of aggregated randomized controlled trials.

Authors:  Janet A Lydecker; Ralitza Gueorguieva; Robin Masheb; Marney A White; Carlos M Grilo
Journal:  Int J Eat Disord       Date:  2019-09-09       Impact factor: 4.861

8.  Predictors and moderators of treatment outcome in a randomized clinical trial for binge-eating disorder.

Authors:  Lisa M Anderson; Kathryn M Smith; Lauren M Schaefer; Ross D Crosby; Li Cao; Scott G Engel; Scott J Crow; Stephen A Wonderlich; Carol B Peterson
Journal:  J Consult Clin Psychol       Date:  2020-04-27

9.  Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.

Authors:  Carlos M Grilo; Janet A Lydecker; Peter T Morgan; Ralitza Gueorguieva
Journal:  Clin Ther       Date:  2020-11-18       Impact factor: 3.393

10.  Randomized Controlled Trial of Treatments for Loss-of-Control Eating Following Bariatric Surgery.

Authors:  Carlos M Grilo; Valentina Ivezaj; Andrew J Duffy; Ralitza Gueorguieva
Journal:  Obesity (Silver Spring)       Date:  2021-03-10       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.